Baillargeon Jacques, Giordano Thomas P, Rich Josiah D, Wu Z Helen, Wells Katherine, Pollock Brad H, Paar David P
Department of Preventive Medicine and Community Health, University of Texas Medical Branch, 301 University Blvd, Mail Route 1007, Galveston, TX 77555, USA.
JAMA. 2009 Feb 25;301(8):848-57. doi: 10.1001/jama.2009.202.
Interruption of antiretroviral therapy (ART) during the first weeks after release from prison may increase risk for adverse clinical outcomes, transmission of human immunodeficiency virus (HIV), and drug-resistant HIV reservoirs in the community. The extent to which HIV-infected inmates experience ART interruption following release from prison is unknown.
To determine the proportion of inmates who filled an ART prescription within 60 days after release from prison and to examine predictors of this outcome.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of all 2115 HIV-infected inmates released from the Texas Department of Criminal Justice prison system between January 2004 and December 2007 and who were receiving ART before release.
Proportion of inmates who filled an ART prescription within 10, 30, and 60 days of release from prison.
Among the entire study cohort (N = 2115), an initial prescription for ART was filled by 115 (5.4%) inmates within 10 days of release (95% confidence interval [CI], 4.5%-6.5%), by 375 (17.7%) within 30 days (95% CI, 16.2%-19.4%), and by 634 (30.0%) within 60 days (95% CI, 28.1%-32.0%). In a multivariate analysis of predictors (including sex, age, race/ethnicity, viral load, duration of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program application assistance), Hispanic and African American inmates were less likely to fill a prescription within 10 days (adjusted estimated risk ratio [RR], 0.4 [95% CI, 0.2-0.8] and 0.4 [95% CI, 0.3-0.7], respectively) and 30 days (adjusted estimated RR, 0.7 [95% CI, 0.5-0.9] and 0.7 [95% CI, 0.5-0.9]). Inmates with an undetectable viral load were more likely to fill a prescription within 10 days (adjusted estimated RR, 1.8 [95% CI, 1.2-2.7]), 30 days (1.5 [95% CI, 1.2-1.8]), and 60 days (1.3 [95% CI, 1.1-1.5]). Inmates released on parole were more likely to fill a prescription within 30 days (adjusted estimated RR, 1.3 [95% CI, 1.1-1.6]) and 60 days (1.5 [95% CI, 1.4-1.7]). Inmates who received assistance completing a Texas AIDS Drug Assistance Program application were more likely to fill a prescription within 10 days (adjusted estimated RR, 3.1 [95% CI, 2.0-4.9]), 30 days (1.8 [95% CI, 1.4-2.2]), and 60 days (1.3 [95% CI, 1.1-1.4]).
Only a small percentage of Texas prison inmates receiving ART while incarcerated filled an initial ART prescription within 60 days of their release.
从监狱释放后的最初几周内中断抗逆转录病毒疗法(ART)可能会增加不良临床结局、人类免疫缺陷病毒(HIV)传播以及社区中耐药HIV储存库的风险。HIV感染囚犯出狱后经历ART中断的程度尚不清楚。
确定出狱后60天内开具ART处方的囚犯比例,并检查这一结果的预测因素。
设计、地点和参与者:对2004年1月至2007年12月期间从德克萨斯州刑事司法部监狱系统释放的所有2115名HIV感染囚犯进行回顾性队列研究,这些囚犯在出狱前接受ART治疗。
出狱后10天、30天和60天内开具ART处方的囚犯比例。
在整个研究队列(N = 2115)中,115名(占5.4%)囚犯在出狱后10天内开具了ART初始处方(95%置信区间[CI],4.5%-6.5%),375名(占17.7%)在30天内开具(95%CI,16.2%-19.4%),634名(占30.0%)在60天内开具(95%CI,28.1%-32.0%)。在对预测因素的多变量分析中(包括性别、年龄、种族/族裔、病毒载量、ART持续时间、出院年份、监禁时间、假释以及艾滋病药物援助计划申请援助),西班牙裔和非裔美国囚犯在10天内(调整后的估计风险比[RR]分别为0.4[95%CI,0.2-0.8]和0.4[95%CI,0.3-0.7])和30天内(调整后的估计RR分别为0.7[95%CI,0.5-0.9]和0.7[95%CI,0.5-0.9])开具处方的可能性较小。病毒载量不可检测的囚犯在10天内(调整后的估计RR为1.8[95%CI,1.2-2.7])、30天内(1.5[95%CI,1.2-1.8])和60天内(1.3[95%CI,1.1-1.5])开具处方的可能性更大。假释出狱的囚犯在30天内(调整后的估计RR为1.3[95%CI,1.1-1.6])和60天内(1.5[95%CI,1.4-1.7])开具处方的可能性更大。获得帮助完成德克萨斯州艾滋病药物援助计划申请的囚犯在10天内(调整后的估计RR为3.1[95%CI,2.0-4.9])、30天内(1.8[95%CI,1.4-2.2])和60天内(1.3[95%CI,1.1-1.4])开具处方的可能性更大。
在德克萨斯州,只有一小部分在监禁期间接受ART治疗的囚犯在出狱后60天内开具了ART初始处方。